Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-ÐºB signaling pathway in colorectal cancer cells

Article ID	Journal	Published Year	Pages	File Type
8518507	Phytomedicine	2018	23 Pages	PDF

Keywords

NF-κB HCT-116 cells Pristimerin LPS IKK IκBα 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide IκBα kinase MAPK MTT NF-кB Akt tumor necrosis factor-α Colorectal cancer TNF-α nuclear factor-κB lipopolysaccharide inhibitor of NF-κB mitogen-activated protein kinase CRC

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Clinical Biochemistry

Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-ÐºB signaling pathway in colorectal cancer cells

Authors

Bashir A. Yousef, Hozeifa M. Hassan, Lu-Yong Zhang, Zhen-Zhou Jiang,